Sanofi
COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME
Last updated:
Abstract:
The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.
Status:
Application
Type:
Utility
Filling date:
24 Dec 2020
Issue date:
29 Jul 2021